Kymera Therapeutics, Inc. (KYMR)
82.21
-2.29
(-2.71%)
USD |
NASDAQ |
May 15, 16:00
82.23
+0.02
(+0.02%)
After-Hours: 20:00
Kymera Therapeutics Profit Margin (Quarterly) : -201.5% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 28.94% |
| Revolution Medicines, Inc. | -- |
| Catalyst Pharmaceuticals, Inc. | 42.66% |
| Regeneron Pharmaceuticals, Inc. | 20.17% |
| AbbVie, Inc. | 4.58% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.05% |
| Return on Assets | -24.00% |
| Return on Invested Capital | -25.23% |
| Gross Profit Margin (Quarterly) | 94.12% |
| Operating Margin (Quarterly) | -244.9% |
| Return on Net Operating Assets | -310.4% |